Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Epidemiologia E Psichiatria Sociale
|
July 11, 2007
Explanatory and pragmatic trials
Corrado Barbui, Antonio Veronese, Andrea Cipriani
European Journal of Clinical Pharmacology
|
July 11, 2007
Benzodiazepine use in the real world of psychiatric practice: low-dose, long-term drug taking and low rates of treatment discontinuation
Antonio Veronese, Massimo Garatti, Andrea Cipriani, et al.
American Journal of Physical Medicine & Rehabilitation
|
December 24, 2011
Work disability and depressive disorders: impact on the European population
Antonio Veronese, José Luis Ayuso-Mateos, Maria Cabello, et al.
Epidemiologia E Psichiatria Sociale
|
October 18, 2008
Understanding antipsychotic non-classical prescriptions: a quantitative and qualitative approach
Antonio Veronese, Valerio Vivenza, Michela Nosè, et al.
The Cochrane Database of Systematic Reviews
|
October 1, 2014
Paroxetine versus other anti-depressive agents for depression
Andrea Cipriani, Toshi A Furukawa, Antonio Veronese, et al.
International Clinical Psychopharmacology
|
August 16, 2008
Is the Defined Daily Dose system a reliable tool for standardizing antipsychotic dosages?
Michela Nosè, Michele Tansella, Graham Thornicroft, et al.
Journal of Clinical Psychopharmacology
|
April 22, 2011
Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trial
Corrado Barbui, Simone Accordini, Michela Nosè, et al.
Trials
|
May 19, 2009
Rationale and design of an independent randomised controlled trial evaluating the effectiveness of aripiprazole or haloperidol in combination with clozapine for treatment-resistant schizophrenia
Michela Nosè, Simone Accordini, Paola Artioli, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Epidemiologia E Psichiatria Sociale
|
July 11, 2007
Explanatory and pragmatic trials
Corrado Barbui, Antonio Veronese, Andrea Cipriani
European Journal of Clinical Pharmacology
|
July 11, 2007
Benzodiazepine use in the real world of psychiatric practice: low-dose, long-term drug taking and low rates of treatment discontinuation
Antonio Veronese, Massimo Garatti, Andrea Cipriani, et al.
American Journal of Physical Medicine & Rehabilitation
|
December 24, 2011
Work disability and depressive disorders: impact on the European population
Antonio Veronese, José Luis Ayuso-Mateos, Maria Cabello, et al.
Epidemiologia E Psichiatria Sociale
|
October 18, 2008
Understanding antipsychotic non-classical prescriptions: a quantitative and qualitative approach
Antonio Veronese, Valerio Vivenza, Michela Nosè, et al.
The Cochrane Database of Systematic Reviews
|
October 1, 2014
Paroxetine versus other anti-depressive agents for depression
Andrea Cipriani, Toshi A Furukawa, Antonio Veronese, et al.
International Clinical Psychopharmacology
|
August 16, 2008
Is the Defined Daily Dose system a reliable tool for standardizing antipsychotic dosages?
Michela Nosè, Michele Tansella, Graham Thornicroft, et al.
Journal of Clinical Psychopharmacology
|
April 22, 2011
Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trial
Corrado Barbui, Simone Accordini, Michela Nosè, et al.
Trials
|
May 19, 2009
Rationale and design of an independent randomised controlled trial evaluating the effectiveness of aripiprazole or haloperidol in combination with clozapine for treatment-resistant schizophrenia
Michela Nosè, Simone Accordini, Paola Artioli, et al.
Page
of 1